March 30, 2026

Glaukos Corporation (GKOS) Stock Analysis: 34% Potential Upside Shines in the Medical Device Sector

In the ever-evolving landscape of healthcare, Glaukos Corporation (GKOS) stands out as a pioneering force in the medical devices industry. With a market capitalization of $5.99..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: Exploring the 79% Upside Potential

iRhythm Holdings, Inc. (NASDAQ: IRTC), a key player in the healthcare sector specializing in medical devices, is garnering significant attention from investors with its innovative cardiac..

ICON plc (ICLR) Stock Analysis: Navigating a 31.95% Potential Upside in the Healthcare Sector

For investors eyeing opportunities in the healthcare sector, ICON plc (ICLR) presents a compelling case for consideration. As a leading clinical research organization based in Dublin,..

Legend Biotech Corporation (LEGN): A Biotech Powerhouse with a Potential Upside of 240%

Legend Biotech Corporation (NASDAQ: LEGN) stands as a formidable player in the biotechnology sector, offering a compelling investment story centered on its groundbreaking work in cell..

Fresenius Medical Care AG (FMS) Stock Analysis: Examining a 22.98% Potential Upside Amidst Challenges

Fresenius Medical Care AG (NYSE: FMS), a cornerstone in the healthcare sector specializing in dialysis services, stands as a pivotal player globally. With its operations spanning..

Chemed Corp (CHE) Stock Analysis: Exploring a 20% Potential Upside Amidst Market Challenges

For investors seeking stability in the healthcare sector, Chemed Corp (NYSE: CHE) presents an intriguing opportunity. With a current market capitalization of $5.2 billion, Chemed operates..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: A Bold Bet on Biotech with 249% Upside Potential

Soleno Therapeutics, Inc. (SLNO) presents a compelling opportunity for investors seeking exposure to the biotechnology sector, particularly those interested in companies focusing on rare disease therapeutics...

Telix Pharmaceuticals Limited (TLX) Stock Analysis: A Biotech Powerhouse with 125% Upside Potential

Telix Pharmaceuticals Limited (ASX: TLX) has emerged as a significant player in the biotechnology sector, captivating investor interest with its innovative approach to radiopharmaceuticals. The Australian-based..

Bruker Corporation (BRKR) Stock Analysis: Exploring a 41.93% Upside in the Medical Devices Sector

Bruker Corporation (NASDAQ: BRKR), a key player in the healthcare sector specializing in medical devices, presents an intriguing case for investors seeking opportunities within the scientific..

AptarGroup, Inc. (ATR) Stock Analysis: A 33.62% Potential Upside in the Healthcare Sector

AptarGroup, Inc. (NYSE: ATR) is a noteworthy player in the healthcare sector, specializing in medical instruments and supplies. With a market capitalization of $7.85 billion, the..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Exploring a 20% Upside Potential in the Healthcare Sector

Bausch + Lomb Corporation (NYSE: BLCO), a stalwart in the healthcare sector, is captivating investor attention with its robust product offerings in the medical instruments and..

Insulet Corporation (PODD) Stock Analysis: Exploring a 68.78% Potential Upside for Investors

Insulet Corporation (NASDAQ: PODD) stands at the forefront of the medical devices sector, focusing on innovative insulin delivery systems. As the healthcare industry continues to evolve,..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Exploring a Potential 58.42% Upside

Inspire Medical Systems, Inc. (NASDAQ: INSP), a pioneering force in the medical devices sector, has captured investor attention with its innovative approach to treating obstructive sleep..

Atrium Therapeutics, Inc. (RNA) Stock Analysis: Unpacking an 88.96% Potential Upside Amidst Revenue Challenges

Atrium Therapeutics, Inc. (NASDAQ: RNA) is making waves in the biotechnology sector with its focus on RNA therapeutics aimed at treating cardiomyopathies. Despite facing significant revenue..

Rhythm Pharmaceuticals (RYTM): Analyst Ratings Signal 81% Potential Upside for Biotechnology Innovator

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM), a dynamic player in the biotechnology sector, presents an intriguing opportunity for investors eyeing significant growth potential. The Boston-based company, specializing..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: Exploring a 30.92% Potential Upside for Investors

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a dynamic player in the biotechnology sector, has captured the attention of investors with its focus on novel therapeutics for metabolic..

ResMed Inc. (RMD) Stock Analysis: Exploring a 34.65% Potential Upside in the Healthcare Sector

ResMed Inc. (NYSE: RMD), a titan in the healthcare sector, specializes in developing and marketing innovative medical devices and cloud-based software applications aimed at managing respiratory..

Oscar Health, Inc. (OSCR)

⚠️ No article content returned.

..

TransMedics Group, Inc. (TMDX) Stock Analysis: A Promising 62.85% Upside Potential for Investors

TransMedics Group, Inc. (NASDAQ: TMDX) presents an intriguing opportunity for investors in the medical technology sector, particularly those focused on innovative healthcare solutions. The company, headquartered..

Nuvalent, Inc. (NUVL) Stock Analysis: A Potential 48.91% Upside in the Biotech Sector

Nuvalent, Inc. (NASDAQ: NUVL), a dynamic player in the biotechnology sector, is currently making waves in the healthcare industry with its innovative approach to cancer treatment...

Search

Funds

March 30, 2026

Search

Funds

March 30, 2026

FTSE 100

Funds